Overview
Biotechnology and pharmaceutical manufacturers must recognize, understand, and address many legal and regulatory requirements associated with the research, development, pricing, promotion, marketing, and selling of their respective services and products—domestically and internationally.
The biotechnology and pharmaceutical industries continue to receive significant scrutiny from the public; federal, state, and international regulators; elected officials; and enforcement agencies. Therefore, entities operating in these industries must remain even more vigilant and knowledgeable about the legal and regulatory parameters affecting their companies to stay compliant and proactive and minimize risk.
Epstein Becker Green counsels companies and institutions operating in the different segments of biotechnology and pharmaceutical industries domestically and internationally. We provide comprehensive legal services relating to all aspects of the development of products, the U.S. Food and Drug Administration (FDA) regulatory approval process, government and third-party reimbursement concerns, and post-approval marketing, commercialization, and compliance requirements. Firm attorneys publish and present extensively at leading industry events and work actively on behalf of firm clients to both educate and advocate to federal and state government agencies and regulators on significant industry issues.
Services/Scope of Practice
Development of Life Science Products and FDA Regulatory Approval
- Providing FDA counseling relating to clinical trial registries and databases, grant-making procedures, and relationships with physicians investigators, and research institutions
- Developing and negotiating co-development, co-promotion, outsourcing, and other strategic research, development, and collaboration agreements
- Providing FDA counseling relating to labeling and advertising claims
Government and Third-Party Reimbursement
- Counseling on government pricing programs, including Medicaid Best Price, Average Sales Price, Competitive Acquisition Program, the Federal Supply Schedule, and the Public Health Service Act, as well as on VA pricing issues
- Providing counseling and strategic planning assistance regarding federal and state drug and device reimbursement programs
- Advising on the processes and strategies for obtaining coverage, coding, and payment for drugs and devices by government and private payors
- Providing regulatory counseling regarding product discount/rebate arrangements with distributors, group purchasing organizations, managed care organizations, long-term care facilities, physicians, institutions, specialty pharmaceutical suppliers, federal and state purchasers (including state pharmaceutical assistance programs (or "SPAPs") and other state and federal pharmaceutical programs), and other purchasers
- Providing antitrust counsel related to manufacturer pricing issues
- Counseling on license agreements and co-promotional activities
Post-Approval Marketing, Commercialization, and Compliance
- Providing all facets of fraud and abuse counseling to manufacturers and their direct and indirect customers and/or purchasers relating to sales programs, marketing initiatives, and other collaborative programs and relationships, including disease management, medication therapy management, coupons, samples and sample cards, reimbursement support, grants, and patient assistant programs
- Providing advice relating to all aspects of health reform regulations, including the Sunshine Act and state reporting laws
- Supporting and counseling on manufacturer new product launches
- Providing health regulatory counsel relating to distribution and fee-for-service arrangements with managed care plans and consumers
- Providing FDA counseling relating to promotional matters, non-promotional activities, continuing medical education activities, and good clinical and laboratory practices
- Providing all facets of counsel regarding post-market clinical trial research programs and grant administration
- Counseling on licensure and other accreditation standards
- Providing HIPAA privacy and security counseling relating to manufacturing, research, and marketing issues
Investigations, Litigation, and Administrative Matters
- Defending manufacturers in connection with false claim qui tam actions and other federal, state, and congressional health care fraud investigations and inquiries
- Negotiating corporate integrity agreements (CIAs) with the U.S. Department of Health and Human Services' Office of Inspector General (OIG)
- Assisting with the implementation and monitoring of CIA compliance
- Providing counsel regarding the submission of voluntary disclosures to the OIG and/or other relevant regulators
- Defending manufacturers and their research partners in private actions related to clinical trial noncompliance and misconduct
- Preparing and assisting manufacturers for appearances at FDA administrative hearings
- Assisting manufacturers in responding to warning letters, notice-of-violation letters, and congressional inquiries
Corporate Compliance
- Developing and implementing all aspects of corporate compliance programs for manufacturers and their direct and indirect customers
- Conducting corporate effectiveness reviews/assessments of corporate compliance programs
- Developing training programs on corporate compliance for marketing and sales forces
- Assisting with the development of reporting systems and compliance monitoring and auditing priorities
- Assisting manufacturers with gap assessments and Board assessments
- Providing counsel in connection with internal compliance investigations
- Developing clinical trial research corporate compliance programs for manufacturers, clinical research organizations, and site management organizations, including compliance with Good Clinical Practices, human subject protection compliance procedures, and procedures regarding investigator-initiated research
- Developing research compliance programs addressing relationships with research sites, researchers, vendors, professional organizations, independent foundations, and other participants in the clinical research process
Policy and Legislation
- Monitoring and analyzing pending federal and state legislation, rulemaking, regulations, and guidance
- Providing assistance with the submission of comments in connection with pending legislation and proposed rules, regulations, and guidance
- Assisting with the preparation of testimony in connection with pending legislation
- Providing counsel regarding federal and state marketing, disclosure, sales, gifts, compliance programs, pricing, clinical trials, pedigree, and related reporting requirements
- Providing legislative industry updates and analyses
Federal and State Transparency Reporting
- Counseling clients on federal and state reporting requirements
- Conducting gap assessments
- Correcting compliance implementation deficiencies
- Addressing infrastructure and resource matters
- Implementing aggregate spend reporting systems
- Drafting policies, procedures, and working instructions
- Training employees, vendors, and health care professionals
- Responding to government agencies and proposed regulations
- Analyzing preemption matters
- Informing clients of federal and state law developments
Read less
Focus Areas
Services
Industries
Trending Issues
Experience
Contacts
- Member of the Firm
- Board of Directors / Member of the Firm
- Member of the Firm
Media
Events
Upcoming Events
Past Events
- December 10-11, 2024
Insights
Insights
- PublicationsWhat Does the Phrase “Resulting From” Mean? Circuit Courts Split on Standard for Determining When an AKS Violation Is a ...16 minute read
- PublicationsACIP’s Upcoming Meningococcal Recommendations: Added Complexity, Reduced Choice1 minute read
- Media CoverageRichard Hughes Quoted in “CDC Plans Study on Vaccines and Autism Despite Research Showing No Link”4 minute read
- Media CoverageRichard Hughes Quoted in “Trump’s FDA Nominee Grilled on Vaccine Meeting, Agency Staffing”8 minute read
- PublicationsProposed HIPAA Security Rule Updates May Significantly Impact Covered Entities and Business Associates20 minute read
- Media CoverageRichard Hughes Quoted in “Kennedy's Early Warning Signs on Vaccine Policy”4 minute read
- PublicationsExpanding Vaccination Provider Types and Administration Sites Can Increase Vaccination Uptake: A Systematic Literature ...2 minute read
- Media Coverage
Richard Hughes Discusses Why Payer Responsibility for Preventative Services May Hinge on Braidwood Management Inc. v ...
4 minute read - Media CoverageRichard Hughes Quoted in “Expert: Removing Shots from Childhood Schedule Would Nix Compensation”2 minute read
- Media CoverageRichard Hughes Quoted in “F.D.A. Cancels Meeting of Vaccine Experts Scheduled to Advise on Flu Shots”2 minute read
- Media CoverageRichard Hughes Quoted in “Could ACIP Delay Wind Up in Court?”2 minute read
- PublicationsProtecting Newborns from RSV: Opening a Reimbursement Pathway2 minute read
- Media Coverage
Richard Hughes Discusses the Major Implications of Braidwood Management Inc. v. Becerra on Available Preventive Services ...
3 minute read - Media CoverageRichard Hughes Quoted in “Key CDC Vaccine Committee Meeting Pushed Back”2 minute read
- PublicationsHealthcare M&A Insights: Q4 2024 & 2025 Look Ahead4 minute read
- Media CoverageRichard Hughes Quoted in “Parents, Medical Providers, Vaccine Experts Brace for RFK Jr.’s HHS Takeover”4 minute read
- Media CoverageRichard Hughes Quoted in “RFK Jr. Says Vaccines Aren’t Tested Enough. Experts Say That’s Baseless.”2 minute read
- Media CoverageRichard Hughes Quoted in “The $8 Billion Children’s Vaccine Fund Kennedy Would Oversee”2 minute read
- Media CoverageRichard Hughes Quoted in “The Powerful Vaccine Committee RFK Jr. Could Soon Control”2 minute read
- PublicationsThe Lingering Legacy of Thimerosal2 minute read
- BlogsAt Long Last, DEA’s Remote Prescribing Rules 2.0 Are (Really) Here! (Pending Further Consideration by the Incoming ...18 minute read
- Media CoverageFlourish: Breaking Healthcare’s Glass Ceiling – a Legal Pioneer’s Journey, with Lynn Shapiro Snyder2 minute read
- Media CoverageRichard Hughes Quoted in “ACA Suit Threatens Overhaul of Preventive Care in Employer Plans”2 minute read
- Media CoverageRichard Hughes Quoted in “How RFK Jr. Drove Mistrust of a Cancer Prevention Vaccine”7 minute read
- Media CoverageRichard Hughes Quoted in “Supreme Court Case Offers Trump Path to Dismantle Obamacare Mandates”5 minute read
- Media CoverageRichard Hughes Quoted in “Supreme Court to Hear ACA Preventive Coverage Suit”4 minute read
- Media CoverageRichard Hughes Quoted in “Supreme Court to Hear ACA Preventive Care Case”1 minute read
- Media CoverageRichard Hughes Quoted in “Biden Admin Finalizes NBPP, MA Pay Rules Ahead of Departure”2 minute read
- Media CoverageRichard Hughes Quoted in “SCOTUS to Review ACA’s Free Preventative Services Mandate”2 minute read
- BlogsMassachusetts Governor Maura Healey Signs into Law a Sweeping Health Care Market Oversight Bill12 minute read
- BlogsSecond Circuit Adopts “At Least One Purpose” Rule for False Claims Act Cases Premised on Anti-Kickback Statute ...8 minute read
- Media CoverageRichard Hughes Quoted in “Obamacare Case Presents Renewed Opportunity to Restrict Agencies”4 minute read
- Media CoverageRichard Hughes Quoted in “RFK Jr. Could Reshape Vaccine Injury Program, Add Autism”2 minute read
- Media CoverageRichard Hughes Provides Historical Perspective on Vaccine Use in the 20th Century1 minute read
- Media CoverageJames Boiani Quoted in “Supplement Makers Try to Latch On to GLP-1 Boom”2 minute read
- PublicationsMedicare Coverage of Antiobesity Medicines1 minute read
- Media CoverageHealth Podyssey: Richard Hughes, IV, on States’ Response to Federal Vaccine Recommendations for Schools1 minute read
- BlogsNew Jersey General Assembly Passes Legislation Prohibiting Sale of Diet Pills, Weight Loss/Muscle Building Supplements to ...6 minute read
- Media Coverage
Featured in Law360: Epstein Becker Green Adds Research Compliance Pro Elizabeth McEvoy
2 minute read - Firm AnnouncementsEpstein Becker Green Welcomes High-Stakes Research Misconduct Attorney and Litigator Elizabeth J. McEvoy, Improves Bench ...3 minute read
- Media CoverageRichard Hughes Quoted in “5 Ways Trump's Election Could Change Employee Benefits”2 minute read
- PublicationsNow Is Not the Time to Undo Adolescent Vaccination Policies2 minute read
- Media CoverageRichard Hughes Quoted in “Scientists and RFK Jr. Want Vaccine Data—for Very Different Reasons”3 minute read
- PublicationsSchool-Entry Vaccine Policies: States’ Responses to Federal Recommendations Varied from Swift to Substantially ...5 minute read
- PublicationsThe Advent and Future of Self-Administered Vaccines2 minute read
- Media CoverageErin Sutton Quoted in “3 Things to Know About Proposed OTC Contraception Regs”3 minute read
- PublicationsAre We Ready for a Bird Flu Vaccination Campaign?2 minute read
- PublicationsThe US Supreme Court and the Uncertain Future of Preventive Care4 minute read
- Media CoverageRichard Hughes Quoted in “Gov't Looks to High Court to Preserve Free Preventive Care”2 minute read
- BlogsVideo: New HIPAA Final Rule - Key Changes to Reproductive Health Care Privacy – Thought Leaders in Health Law3 minute read